B cells imprint adoptively transferred CD8(+) T cells with enhanced tumor immunity

BACKGROUND: Adoptive T cell transfer (ACT) therapy improves outcomes in patients with advanced malignancies, yet many individuals relapse due to the infusion of T cells with poor function or persistence. Toll-like receptor (TLR) agonists can invigorate antitumor T cell responses when administered di...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Aubrey S, Knochelmann, Hannah M, Wyatt, Megan M, Rangel Rivera, Guillermo O, Rivera-Reyes, Amalia M, Dwyer, Connor J, Ware, Michael B, Cole, Anna C, Neskey, David M, Rubinstein, Mark P, Liu, Bei, Thaxton, Jessica E, Bartee, Eric, Paulos, Chrystal M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753437/
https://www.ncbi.nlm.nih.gov/pubmed/35017148
http://dx.doi.org/10.1136/jitc-2021-003078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753437/
https://www.ncbi.nlm.nih.gov/pubmed/35017148
http://dx.doi.org/10.1136/jitc-2021-003078

Ejemplares similares